Structural Basis for Pore Blockade of the Human Cardiac Sodium Channel Nav1.5 by the Antiarrhythmic Drug Quinidine**

被引:80
作者
Li, Zhangqiang [1 ]
Jin, Xueqin [1 ]
Wu, Tong [1 ]
Huang, Gaoxingyu [2 ]
Wu, Kun [3 ]
Lei, Jianlin [4 ]
Pan, Xiaojing [1 ]
Yan, Nieng [5 ]
机构
[1] Tsinghua Univ, State Key Lab Membrane Biol, Beijing Adv Innovat Ctr Struct Biol, Sch Life Sci,V, Beijing 100084, Peoples R China
[2] Westlake Univ, Sch Life Sci, Westlake Inst Adv Study, Key Lab Struct Biol Zhejiang Prov,Inst Biol, Hangzhou 310024, Zhejiang, Peoples R China
[3] Capital Med Univ, Beijing Chao Yang Hosp, Med Res Ctr, Beijing Key Lab Cardiopulm Cerebral Resuscitat, Beijing 100020, Peoples R China
[4] Tsinghua Univ, Technol Ctr Prot Sci, Minist Educ, Key Lab Prot Sci,Sch Life Sci, Beijing 100084, Peoples R China
[5] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA
关键词
antiarrhythmic drugs; cryo-EM structure; quinidine; voltage-gated Na+ (Na-v) channels;
D O I
10.1002/anie.202102196
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Na(v)1.5, the primary voltage-gated Na+ (Na-v) channel in heart, is a major target for class I antiarrhythmic agents. Here we present the cryo-EM structure of full-length human Na(v)1.5 bound to quinidine, a class Ia antiarrhythmic drug, at 3.3 angstrom resolution. Quinidine is positioned right beneath the selectivity filter in the pore domain and coordinated by residues from repeats I, III, and IV. Pore blockade by quinidine is achieved through both direct obstruction of the ion permeation path and induced rotation of an invariant Tyr residue that tightens the intracellular gate. Structural comparison with a truncated rat Na(v)1.5 in the presence of flecainide, a class Ic agent, reveals distinct binding poses for the two antiarrhythmics within the pore domain. Our work reported here, along with previous studies, reveals the molecular basis for the mechanism of action of class I antiarrhythmic drugs.
引用
收藏
页码:11474 / 11480
页数:7
相关论文
共 53 条
[1]   Ion Channel Macromolecular Complexes in Cardiomyocytes: Roles in Sudden Cardiac Death [J].
Abriel, Hugues ;
Rougier, Jean-Sebastien ;
Jalife, Jose .
CIRCULATION RESEARCH, 2015, 116 (12) :1971-1988
[2]   SODIUM-CHANNELS AND GATING CURRENTS [J].
ARMSTRONG, CM .
PHYSIOLOGICAL REVIEWS, 1981, 61 (03) :644-683
[3]   MOLECULAR MECHANISM FOR AN INHERITED CARDIAC-ARRHYTHMIA [J].
BENNETT, PB ;
YAZAWA, K ;
MAKITA, N ;
GEORGE, AL .
NATURE, 1995, 376 (6542) :683-685
[4]   Congenital sick sinus syndrome caused by recessive mutations in the cardiac sodium channel gene (SCN5A) [J].
Benson, DW ;
Wang, DW ;
Dyment, M ;
Knilans, TK ;
Fish, FA ;
Strieper, MJ ;
Rhodes, TH ;
George, AL .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (07) :1019-1028
[5]   Reducing safety-related drug attrition: the use of in vitro pharmacological profiling [J].
Bowes, Joanne ;
Brown, Andrew J. ;
Hamon, Jacques ;
Jarolimek, Wolfgang ;
Sridhar, Arun ;
Waldron, Gareth ;
Whitebread, Steven .
NATURE REVIEWS DRUG DISCOVERY, 2012, 11 (12) :909-922
[6]   EVIDENCE FOR A SPECIFIC RECEPTOR-SITE FOR LIDOCAINE, QUINIDINE, AND BUPIVACAINE ASSOCIATED WITH CARDIAC SODIUM-CHANNELS IN GUINEA-PIG VENTRICULAR MYOCARDIUM [J].
CLARKSON, CW ;
HONDEGHEM, LM .
CIRCULATION RESEARCH, 1985, 56 (04) :496-506
[7]   Sequential formation of ion pairs during activation of a sodium channel voltage sensor [J].
DeCaen, Paul G. ;
Yarov-Yarovoy, Vladimir ;
Sharp, Elizabeth M. ;
Scheuer, Todd ;
Catterall, William A. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (52) :22498-22503
[8]   Disulfide locking a sodium channel voltage sensor reveals ion pair formation during activation [J].
DeCaen, Paul G. ;
Yarov-Yarovoy, Vladimir ;
Zhao, Yong ;
Scheuer, Todd ;
Catterall, William A. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (39) :15142-15147
[9]   Utility of frozen cell lines in medium throughput electrophysiology screening of hERG and Nav1.5 blockade [J].
Donovan, Brian T. ;
Bakshi, Tania ;
Galbraith, Sarah E. ;
Nixon, Christopher J. ;
Payne, Lisa A. ;
Martens, Stan F. .
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2011, 64 (03) :269-276
[10]   ANTIARRHYTHMIC DRUG-THERAPY AND CARDIAC MORTALITY IN ATRIAL-FIBRILLATION [J].
FLAKER, GC ;
BLACKSHEAR, JL ;
MCBRIDE, R ;
KRONMAL, RA ;
HALPERIN, JL ;
HART, RG .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1992, 20 (03) :527-532